WealthShield Partners’s Immunogen Inc IMGN Stock Holding History

WealthShield Partners’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-113	Closed	-$1K	–	1199
2021 Q1	$1K	Buy	+113	New	+$923	﹤0.01%	1129

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WealthShield Partners's IMGN Position: Q2 2021 in Review

WealthShield Partners sold out of Immunogen Inc (IMGN) in Q2 2021, closing a stake of 113 shares — an estimated $1K sold.

WealthShield Partners first reported a position in IMGN in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 214 funds tracked by Wall St. Rank hold IMGN as of Q2 2021.

WealthShield Partners reported no remaining Immunogen Inc position as of Q2 2021 after selling out during the quarter.
WealthShield Partners sold 113 Immunogen Inc shares in Q2 2021, an estimated $1K.
WealthShield Partners first reported a position in Immunogen Inc in Q1 2021 and held it in 1 quarter.
WealthShield Partners's Immunogen Inc position peaked at $1K in Q1 2021.
214 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2021.

Based on WealthShield Partners's 13F filing for Q2 2021, filed 6 Aug 2021.